logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10544137 B1

PDFFull Text
Date of Patent:
Jan. 28, 2020

Filed:

May. 31, 2017

Pi3k inhibitor, and pharmaceutically acceptable salt, polycrystalline form, and application thereof

Applicants:

Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Shanghai, CN;

Yangtze River Pharmaceutical Group Co., Ltd., Jiangsu, CN;

Inventors:

Taotao Jiang, Shanghai, CN;

Qiang Xu, Shanghai, CN;

Zhaoling Dan, Shanghai, CN;

Assignees:

SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD., , KR;

YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD., , KR;

Attorney:

Adsero IP

Primary Examiner:

Timothy R Rozof

Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 401/04 (2006.01); A61P 35/02 (2006.01); A61P 35/00 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61K 31/5377 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07D 401/04 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present invention relates to a PI3K inhibitor, and a pharmaceutically acceptable salt, polycrystalline form, and application thereof. The invention specifically provides a polycrystalline form of 4-chloro-5-(6-(1-(methylsulfonyl)cyclopropyl)-2-morpholinopyrimidin-4-yl)pyridin-2-amine, a pharmaceutically acceptable salt thereof, or a polycrystalline form of the salt. The invention further discloses a pharmaceutical composition comprising the inhibitor and an application of the pharmaceutical composition.

Find Patent Forward Citations

Quick Actions:

Jiang, Taotao. (2020). Pi3k inhibitor, and pharmaceutically acceptable salt, polycrystalline form, and application thereof (U.S. Patent No. 10544137). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10544137

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…